Newborn and Infant Nursing Reviews
Volume 6, Issue 2 , Pages 100-105 , June 2006

Inhaled Nitric Oxide

  • Kelly R. Wendel, RN, MSN, NNP
    • ,
  • Amy T. Nathan, MD

      Affiliations

    • Corresponding Author InformationAddress correspondences to Amy T. Nathan, MD, 3333 Burnet Avenue, MLC #7038, Cincinnati, OH 45229.

References 

  1. Ramanathan R. Nitric oxide: what is this stuff?. In: Symposium on Critical Care and Transport; Center for Advanced Medical Education; Children's Hospital of Los Angeles, Oct. 4. 2001;
  2. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524–526
  3. Abman SH, Chatfield BA, Hall SL, McMurty IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:H1921–H1927
  4. Cornfield DN, Chatfield BA, McQueston JA, McMurty IF, Abman SH. Effects of birth-related stimuli on l-arginine–dependent pulmonary vasodilation in ovine fetus. Am J Physiol. 1992;262:H1474–H1481
  5. Kinsella JP, McQueston JA, Rosenberg AA, Abman SH. Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation. Am J Physiol. 1992;263:H875–H880
  6. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide—a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83:2038–2047
  7. Fratacci MD, Frostell CG, Chen TY, Wain JC, Robinson DR, Zapol WM. Inhaled nitric oxide—a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology. 1991;75:990–999
  8. Roberts JD, Chen T-Y. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res. 1993;72:246
  9. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819–820
  10. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:818–819
  11. Tiktinsky MH, Cummings JJ, Morin FC. Acetylcholine increases pulmonary blood flow in intact fetuses via endothelium-dependent vasodilation. Am J Physiol. 1992;262:H406–H410
  12. Fineman JR, Wong J, Morin FC, Wild LM, Soifer SJ. Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs. J Clin Invest. 1994;93(6):2675–2683
  13. Lorch SA, Foust R, Gow A. Immunohistochemical localization of protein 3-nitrotyrosine and S-nitrosocysteine in a murine model of inhaled nitric oxide therapy. Pediatr Res. 2000;47:798–805
  14. Lunn RJ. Inhaled nitric oxide therapy. Mayo Clin Proc. 1995;70(3):247–255
  15. Salguero KL, Cummings JJ. Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn. Pulm Pharm and Therapeutics. 2002;15:1–5
  16. Issa A, Lappalainen U, Kleinman M, Bry K, Hallman M. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res. 1999;45:247–254
  17. Hallman M. Molecular interactions between nitric oxide and lung surfactant. Biol Neonate. 1997;71:44–48
  18. Hallman M, Bry K, Turbow R, Waffarn F, Lappalainen U. Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure. J Pediatr. 1998;132:827–829
  19. Hogman M, Frostell C, Arnberg H, Hedenstierna G. Bleeding time prolongation and NO inhalation. Lancet. 1993;341:1664–1665
  20. Cheung PY, Salas E, Etches PC, Phillipos E, Schulz R, Radomski MW. Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet. 1998;351:1181–1182
  21. Fanaroff M, ed. Neonatal-perinatal medicine. Vol 1 (7 ed). Philadelphia, (PA): Mosby, 417.
  22. NINOS (The Neonatal Inhaled Nitric Oxide Study Group). Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336:597–604
  23. Clark RH, Kueser TJ, Walker MW. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med. 2000;342:469–474
  24. Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Syst Rev. 2000;CD000399
  25. Macrae DJ, Field D, Mercier JC. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med. 2004;30:372–380
  26. Hamon I, Fresson J, Nicolas MB, Buchweiller MC, Frank P, Hascoet JM. Early inhaled nitric oxide improves oxidative balance in very preterm infants. Pediatr Res. 2005;57:637–643
  27. Field D, Elbourne D, Truesdale A. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO Multicentre Randomised Controlled Trial (ISRCTN 17821339). Pediatrics. 2005;115:926–936
  28. Mercier JC, et al. Franco-Belgium collaborative NO trial group Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet. 1999;354:1066–1071
  29. Subhedar NV, Ryan SW, Shaw NJ. Open randomized controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child. 1997;77:F185–F190
  30. Kinsella JP, Walsh WF, Bose CL. Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomized controlled trial. Lancet. 1999;354:1061–1065
  31. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database of Syst Rev. 2000;CD000509
  32. Schreiber MD, Gin-Mestank K, Marks JD, Huo D, Lee G, Srisuparo P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349:2099–2107
  33. Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353:23–32
  34. Field DJ. Nitric oxide—still no consensus. Early Hum Devel. 2005;81:1–4
  35. Van Meurs KP, Wright LL, Ehrenkranz RA. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13–22
  36. Finer NN. Inhaled nitric oxide for preterm infants: a therapy in search of an indication? The search continues. J Pediatr. 2005;146:301–303
  37. Hascoet JM, Fresson J, Claris O. The safety and efficacy of nitric oxide therapy in premature infants. J Pediatr. 2005;146:318–323
  38. Lindwall R, Blennow M, Svensson M. A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome. Intensive Care Med. 2005;31(7):959–964
  39. Martin JR, Walsh MC. Inhaled nitric oxide for preterm infants—who benefits?. N Engl J Med. 2005;353(1):82–84
  40. Roberts JD, Roberts CT, Jones RC, Zapol WM, Bloch KD. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res. 1995;76:215–222
  41. Roberts JD, Chiche JD, Weimann J, Steudel W, Zapol WM, Bloch KD. Nitric oxide inhalation decreases pulmonary artery remodeling in the injured lungs of rat pups. Circ Res. 2000;87:140–145

PII: S1527-3369(06)00046-8

doi: 10.1053/j.nainr.2006.03.010

Newborn and Infant Nursing Reviews
Volume 6, Issue 2 , Pages 100-105 , June 2006

Article Tools

* Image Usage & Resolution